作者: R. Silvestrini , M. G. Daidone
DOI: 10.1007/978-3-642-84745-5_10
关键词: Disease progression 、 Oncology 、 Predictive value 、 Breast cancer 、 Flow cytometry 、 Estrogen receptor positive tumor 、 Medicine 、 Internal medicine
摘要: The growing interest in breast cancer biology and the development of sophisticated techniques have greatly contributed to knowledge cellular molecular aspects disease progression. Markers indicative biological aggressiveness been identified [1], some these already passed from laboratory clinical application as valid prognostic indicators.